{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:45:45Z","timestamp":1761893145512},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.dsx.2017.11.002","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T08:15:54Z","timestamp":1511511354000},"page":"123-127","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Treatment choices for the glycaemic management of patients with type 2 diabetes and chronic kidney disease: Analysis of the SAIL patient linked dataset"],"prefix":"10.1016","volume":"12","author":[{"given":"Thinzar","family":"Min","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth I.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Chess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey W.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dsx.2017.11.002_bib0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/ndt\/gfi163","article-title":"The unrecognized prevalence of chronic kidney disease in diabetes","volume":"21","author":"Middleton","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.dsx.2017.11.002_bib0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1464-5491.2007.02075.x","article-title":"Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice","volume":"24","author":"New","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2017.11.002_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c6624","article-title":"Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database","author":"Hippisley-Cox","year":"2010","journal-title":"BMJ"},{"issue":"2 Suppl 2","key":"10.1016\/j.dsx.2017.11.002_bib0020","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1053\/j.ajkd.2013.10.049","article-title":"Glycemic management in ESRD and earlier stages of CKD","volume":"63","author":"Williams","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.dsx.2017.11.002_bib0025","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s12325-015-0261-x","article-title":"Rodriguez A, and Salaun-Martin C, Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease","volume":"32","author":"Roussel","year":"2015","journal-title":"Adv Ther"},{"issue":"6","key":"10.1016\/j.dsx.2017.11.002_bib0030","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1681\/ASN.2008080860","article-title":"Prediction, progression, and outcomes of chronic kidney disease in older adults","volume":"20","author":"Anderson","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dsx.2017.11.002_bib0035","first-page":"93","article-title":"The SAIL databank: linking multiple health and social care datasets","author":"Lyons","year":"2009","journal-title":"BMC Med Inform Decis Mak"},{"issue":"4","key":"10.1016\/j.dsx.2017.11.002_bib0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pcd.2009.06.004","article-title":"Use of a patient linked data warehouse to facilitate diabetes trial recruitment from primary care","volume":"3","author":"Brooks","year":"2009","journal-title":"Prim Care Diabetes"},{"issue":"3","key":"10.1016\/j.dsx.2017.11.002_bib0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pcd.2009.06.001","article-title":"Are blood pressure levels taken during a secondary care diabetic clinic likely to be higher than when measured in primary care?","volume":"3","author":"Brooks","year":"2009","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.dsx.2017.11.002_bib0050","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2337\/dc11-0258","article-title":"Comment on: polonsky et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the structured testing program study","volume":"34","author":"Stephens","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2017.11.002_bib0055","series-title":"Data Anonymisation Policy and Process (DAPP) HIRU project document","author":"Ford","year":"2017"},{"key":"10.1016\/j.dsx.2017.11.002_bib0060","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-9-157","article-title":"The SAIL Databank: building a national architecture for e-health research and evaluation","author":"Ford","year":"2009","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.dsx.2017.11.002_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13300-015-0104-4","article-title":"Is there evidence of any safety differences among DPP-4 inhibitors in the treatment of people with type 2 diabetes mellitus and reduced GFR due to chronic kidney disease?","volume":"6","author":"Evans","year":"2015","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.dsx.2017.11.002_bib0070","first-page":"10341","article-title":"How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study","author":"Penfornis","year":"2014","journal-title":"Vasc Health Risk Manag"},{"issue":"10","key":"10.1016\/j.dsx.2017.11.002_bib0075","doi-asserted-by":"crossref","first-page":"e111543","DOI":"10.1371\/journal.pone.0111543","article-title":"Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus patients with moderate to severe renal impairment: a systematic review and meta-analysis","volume":"9","author":"Cheng","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.dsx.2017.11.002_bib0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3810\/pgm.2012.07.2575","article-title":"Use of dipeptidyl peptidase-4 inhibitors for the treatment of patients with type 2 diabetes mellitus and chronic kidney disease","volume":"124","author":"Mikhail","year":"2012","journal-title":"Postgrad Med"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402117303533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402117303533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T20:55:34Z","timestamp":1535230534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402117303533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1871402117303533"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2017.11.002","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment choices for the glycaemic management of patients with type 2 diabetes and chronic kidney disease: Analysis of the SAIL patient linked dataset","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2017.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}